Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gadellaa-van Hooijdonk CGM"'
Autor:
Crouzen JA; Haaglanden Medical Center, The Hague, The Netherlands., Petoukhova AL; Haaglanden Medical Center, The Hague, The Netherlands., Broekman MLD; Haaglanden Medical Center, The Hague, The Netherlands., Fiocco M; Mathematical Institute of Leiden University, Leiden, The Netherlands., Fisscher UJ; Haaglanden Medical Center, The Hague, The Netherlands., Franssen JH; Haga Hospital, The Hague, The Netherlands., Gadellaa-van Hooijdonk CGM; Zuidwest Radiotherapeutisch Instituut, Roosendaal, Vlissingen, The Netherlands., Kerkhof M; Haaglanden Medical Center, The Hague, The Netherlands., Kiderlen M; Haaglanden Medical Center, The Hague, The Netherlands., Mast ME; Haaglanden Medical Center, The Hague, The Netherlands., van Rij CM; Erasmus MC, Rotterdam, The Netherlands., Nandoe Tewarie R; Haaglanden Medical Center, The Hague, The Netherlands., van de Sande MAE; Instituut Verbeeten, Tilburg, The Netherlands., van der Toorn PPG; Catharina Hospital, Eindhoven, The Netherlands., Vlasman R; Radiotherapy Institute Friesland, Leeuwarden, The Netherlands., Vos MJ; Haaglanden Medical Center, The Hague, The Netherlands., van der Voort van Zyp NCMG; Haaglanden Medical Center, The Hague, The Netherlands., Wiggenraad RGJ; Haaglanden Medical Center, The Hague, The Netherlands., Wiltink LM; Leiden University Medical Center, Leiden, The Netherlands., Zindler JD; Haaglanden Medical Center, The Hague, The Netherlands. j.zindler@haaglandenmc.nl.; Holland Proton Therapy Center, Delft, The Netherlands. j.zindler@haaglandenmc.nl.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Mar 25; Vol. 23 (1), pp. 273. Date of Electronic Publication: 2023 Mar 25.
Autor:
Crouzen JA; Haaglanden Medical Center, Department of Radiotherapy, BA Leidschendam, The Netherlands. Electronic address: j.crouzen@haaglandenmc.nl., Petoukhova AL; Haaglanden Medical Center, Department of Medical Physics, BA Leidschendam, The Netherlands. Electronic address: a.petoukhova@haaglandenmc.nl., Wiggenraad RGJ; Haaglanden Medical Center, Department of Radiotherapy, BA Leidschendam, The Netherlands., Hutschemaekers S; Haaglanden Medical Center, Department of Radiotherapy, BA Leidschendam, The Netherlands. Electronic address: s.hutschemaekers@haaglandenmc.nl., Gadellaa-van Hooijdonk CGM; Haaglanden Medical Center, Department of Radiotherapy, BA Leidschendam, The Netherlands., van der Voort van Zyp NCMG; Haaglanden Medical Center, Department of Radiotherapy, BA Leidschendam, The Netherlands. Electronic address: n.van.der.voort.van.zyp@haaglandenmc.nl., Mast ME; Haaglanden Medical Center, Department of Radiotherapy, BA Leidschendam, The Netherlands. Electronic address: m.mast@haaglandenmc.nl., Zindler JD; Haaglanden Medical Center, Department of Radiotherapy, BA Leidschendam, The Netherlands. Electronic address: j.zindler@haaglandenmc.nl.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Aug; Vol. 173, pp. 262-268. Date of Electronic Publication: 2022 Jun 15.
Autor:
Winkel D; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands. Electronic address: d.winkel-2@umcutrecht.nl., Bol GH; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Werensteijn-Honingh AM; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Intven MPW; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Eppinga WSC; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Hes J; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Snoeren LMW; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Sikkes GG; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Gadellaa-van Hooijdonk CGM; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Raaymakers BW; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Jürgenliemk-Schulz IM; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands., Kroon PS; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 May; Vol. 146, pp. 118-125. Date of Electronic Publication: 2020 Mar 06.
Autor:
Weeber F; Center for Personalized Cancer Treatment, The Netherlands.; Department of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Cirkel GA; Center for Personalized Cancer Treatment, The Netherlands.; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Hoogstraat M; Center for Personalized Cancer Treatment, The Netherlands.; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bins S; Center for Personalized Cancer Treatment, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Gadellaa-van Hooijdonk CGM; Center for Personalized Cancer Treatment, The Netherlands.; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands., Ooft S; Department of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Willems SM; Center for Personalized Cancer Treatment, The Netherlands.; Department of Pathology, UMC Utrecht Cancer Center, Utrecht, The Netherlands., van Stralen M; Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands., Veldhuis WB; Department of Radiology, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Besselink NJM; Center for Personalized Cancer Treatment, The Netherlands.; Department of Genetics, UMC Utrecht Center for Molecular Medicine, Utrecht, The Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Steeghs N; Center for Personalized Cancer Treatment, The Netherlands.; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Jonge MJ; Center for Personalized Cancer Treatment, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Langenberg MHG; Center for Personalized Cancer Treatment, The Netherlands.; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Wessels LFA; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands.; Cancer GenomiCs.nl, Utrecht, The Netherlands., Cuppen EPJG; Center for Personalized Cancer Treatment, The Netherlands.; Department of Genetics, UMC Utrecht Center for Molecular Medicine, Utrecht, The Netherlands.; Cancer GenomiCs.nl, Utrecht, The Netherlands.; Hubrecht institute, Utrecht, The Netherlands., Schellens JH; Center for Personalized Cancer Treatment, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Cancer GenomiCs.nl, Utrecht, The Netherlands.; Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Sleijfer S; Center for Personalized Cancer Treatment, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Cancer GenomiCs.nl, Utrecht, The Netherlands., Lolkema MP; Center for Personalized Cancer Treatment, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Voest EE; Center for Personalized Cancer Treatment, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Cancer GenomiCs.nl, Utrecht, The Netherlands.
Publikováno v:
Oncotarget [Oncotarget] 2017 Mar 08; Vol. 8 (33), pp. 55582-55592. Date of Electronic Publication: 2017 Mar 08 (Print Publication: 2017).